karen Piper Hanley

[Daniel J Drucker @DanielJDrucker]

Patience you must have. The SURMOUNT MMO trial design #obesity #Tirzepatide https://t.co/qhGCcSqNRp

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

New from The Lancet Primary Care - Estimating inequality in alcohol-related liver disease burden in the UK, 2009 to 2020: a population-based study using routinely collected data

https://t.co/9GWp9zBUo4

#LiverTwitter #alcohol #UK

[JHEP Reports @JHEP_Reports]

Our tribute to a giant of hepatology, Prof. Michael Manns. His legacy will endure, rest in peace.

[Elliot Jokl @ElliotJokl]

Excellent to see this finally out from the @HanleyPiper lab. Congrats to Nigel et al. on a beautiful paper!
https://t.co/tpeZi8SU3p

[karen Piper Hanley @HanleyPiper]

doi: https://t.co/jrVWG2IIjR

Great to share our recent collaborative work from Andy Sharrocks lab using integrative single cell technologies to understand oesophageal adenocarcinoma.

[ID LIVER @ID_LIVER]

@HanleyPiper & @ElliotJokl discussing how ID LIVER has facilitated the translation of fibrosis biology into biomarker discovery

[ID LIVER @ID_LIVER]

A huge thank you to everyone who joined us at yesterday's dissemination event. It was excellent to see so many of our collaborators together in one place and hear so many interesting discussions across a range of important topics 👏

[Ramon Bataller @rabataller]

Why fatty liver disease progresses more rapidly in WOMEN after menopause ?

This important study in @NatureMedicine shows that variations in ESTROGEN receptors play a key role.

https://t.co/zcqfDJg1Ak #livertwitter @lucavalenti75 @ebugianesi

[Nigel Slone @Nigel_Slone]

The excellent Oliver Street sharing the great work of @ID_LIVER at @innovateuk conference today. Many examples here of the power of industry/academic/NHS collaboration.

[ID LIVER @ID_LIVER]

@VSAthwal presented at #BASL2023 today on how ID LIVER is improving early detection of #LiverDisease

[Nature Reviews Gastroenterology & Hepatology @NatRevGastroHep]

#ICYMI last week online @NatRevGastroHep
"Friend or foe? The elusive role of hepatic stellate cells in liver cancer" a #Review article | Read here: https://t.co/M5YIVv6joW

[The Roger Williams Institute of Liver Studies @Inst_of_Liver]

🤗Just 5 more sleeps...🤗
😴😴😴😴😴
@basl_events Basic Science Retreat 2023
#BBSR2023 #BASLBasic2023
Programme:
https://t.co/EaPS8Ld27q

[Helen Reeves @Helen_ncl_HCC]

We miss Professor Day at EASL, but he was at Buckingham Palace. Congratulations Chris !!😀

[ID LIVER @ID_LIVER]

Neil Guha discussing different pathways for stratifying #LiverDisease risk in primary care

#EASLCongress

[ID LIVER @ID_LIVER]

ID LIVER is developing #MachineLearning models that are superior to FIB-4 as a first line stratification tool for #LiverDisease in the community

Huw Purssell gave a fantastic presentation on the final day of #EASLCongress

[ID LIVER @ID_LIVER]

Goodbye #EASLCongress from the ID LIVER team!

[MFT Research and Innovation @MFT_Research]

The research team, led by Dr Varinder Athwal will implement the new technology across @MFTnhs hospitals. The test aims to improve early detection of the third most common cause of cancer death.

[EASLnews @EASLnews]

🔬 Exciting Findings at #EASLCongress 2023!

Karen Piper Hanley presents groundbreaking research on liver fibrosis at the General Session II. Her study, titled "An Integrative Multi-omic Approach Defines Therapeutic Pathways in Liver Fibrosis," revealed promising insights into altered cell state and chromatin organisation. This innovative approach holds great potential for developing new therapeutic strategies.

[ID LIVER @ID_LIVER]

Disruption to circadian rhythm is linked to #fibrosis risk

Brilliant work @ElliotJokl 👏

[EASL Education @EASLedu]

@ElliotJokl on the topic of circadian rhythm and metabolic syndrome development.
🦉An opportunity for early biomarkers of #LiverDisease detection or a warning to night owls?

#EASLCongress #LiverTwitter